#United States #Lehi #Rural Hospitals #Helmsley Trust #Civica Foundation

Civica Foundation Gains $3.2 Million Grant to Tackle Drug Shortages in Rural Hospitals

The Civica Foundation, a pivotal nonprofit organization dedicated to ensuring access to essential generic medications, has announced that it has secured a significant grant of $3.2 million from the Leona M. and Harry B. Helmsley Charitable Trust. This funding is earmarked for the Civica Rural Hospital Program, a visionary initiative aimed at enhancing the availability of critical drugs in rural and underserved health facilities across nine states.

Launched on May 7, 2026, the Civica Rural Hospital Program is designed to combat the ongoing drug shortages that severely affect rural hospitals. This new initiative will be available to hospitals in Hawaii, Iowa, Minnesota, Montana, Nebraska, Nevada, North Dakota, South Dakota, and Wyoming, regions where healthcare providers often struggle to obtain essential medicines due to a brittle supply chain predominantly relying on a limited number of manufacturers.

Rural hospitals frequently face unique challenges when sourcing generic drugs, particularly low-profit sterile injectables. The current supply chain landscape can be unforgiving; these facilities often lack the larger purchasing power that bolsters larger health systems, resulting in glaring disparities when it comes to drug availability during shortages.

Todd Shellenberger, the President of the Civica Foundation, articulated the critical nature of this initiative: "Drug shortages are hitting rural hospitals especially hard — straining limited staff, disrupting patient care, and driving up costs. The support from Helmsley makes it possible for us to help rural and critical access hospitals join Civica with no membership cost, providing essential medicines precisely when needed."

The Civica Foundation's model allows rural hospitals to become members without bearing preliminary costs, thanks to the grant covering per-bed membership fees. Not only does this alleviate financial burdens, but it also protects against potential shortages through a commitment to consistent supply. The program aims to support roughly 225 rural hospitals, approximately representing 6,750 hospital beds.

Walter Panzirer, a Trustee of the Helmsley Charitable Trust, echoed a commitment to healthcare equity: "We join the Civica Foundation in the mission to make sure every hospital has access to the medications they need. We are committed to enabling rural, underserved hospitals to access a more stable and less price-sensitive supply of generic drugs."

Implementing this pilot program as a three-year initiative marks a crucial step towards leveling the playing field for rural hospitals that grapple with access to affordable medications. Dan Liljenquist, the Chair of the Civica Board of Directors, emphasized the foundation's core values: "From the beginning, Civica was founded on the belief that access to essential medicines should not depend on where you live. The Helmsley Charitable Trust's support will help extend that commitment to rural communities facing the greatest challenges in affordability and supply."

Moreover, it is noteworthy that the Helmsley Charitable Trust has been active in supporting healthcare access initiatives, including efforts to make insulin more affordable across the United States. Earlier this year, Civica announced its entry into the insulin market as part of its broader goal to provide affordable healthcare solutions.

To sum up, the collaboration between the Civica Foundation and the Helmsley Charitable Trust signifies a robust strategy to address the long-standing issue of drug shortages in rural America. By safeguarding access to vital medications, this initiative not only strives to improve patient outcomes but also embodies a significant push towards healthcare equality. Furthermore, it represents a model that could inspire similar collaborative efforts to improve health resource distribution nationwide.

Rural hospitals in the mentioned states interested in partaking in this program can reach out to Michael Laffin directly at his provided contact.

About Civica Foundation and Civica

The Civica Foundation is a 501(c)(3) organization focused on the philanthropic support necessary to manufacture and distribute generic medications affordably for everyone. Since its inception, Civica, a nonprofit pharmaceutical company, has been committed to addressing medication shortages by stabilizing availability, ensuring quality, and expanding access to essential medicines for healthcare systems far and wide.